专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2010058423A9 NOVEL ANTIMICROBIALS 审中-公开
公开(公告)号：WO2010058423A9
公开(公告)日：2010-05-27
申请号：PCT/IN2009/000658
申请日：2009-11-18
申请人： PANACEA BIOTEC LTD. , JAIN, Rajesh , TREHAN, Sanjay , DAS, Jagattaran , KANWAR, Sandeep , MAGADI, Sitaram, Kumar , SHARMA, Sudhir, Kumar
发明人： JAIN, Rajesh , TREHAN, Sanjay , DAS, Jagattaran , KANWAR, Sandeep , MAGADI, Sitaram, Kumar , SHARMA, Sudhir, Kumar
IPC分类号： C07D413/10 , C07D413/14
摘要： The present invention relates to novel phenyl oxazolidinone compounds of formula I, their pharmaceutically acceptable analogs, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to the processes for the synthesis of novel compounds of formula I or their pharmaceutically acceptable analogs, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The present invention also provides pharmaceutical compositions comprising novel compounds of formula I and methods of using them. The compounds of the present invention are useful as antimicrobial agents, effective against a number of aerobic and/or anaerobic Gram positive and/or Gram negative pathogens such as multi drug resistant species of Staphylococcus, Streptococcus, Enterococcus, Bacterioides, Clostridia, H. influenza, Moraxella, acid-fast organisms such as Mycobacterium tuberculosis as well as Linezolid resistant species of Staphylococcus and Enterococcus.

2. 发明申请

WO2009116090A2 NOVEL ANTIMICROBIALS 审中-公开
标题翻译：新的抗生素
公开(公告)号：WO2009116090A2
公开(公告)日：2009-09-24
申请号：PCT/IN2009000184
申请日：2009-03-17
申请人： PANACEA BIOTEC LTD , JAIN RAJESH , TREHAN SANJAY , DAS JAGATTARAN , KANWAR SANDEEP , MAGADI SITARAM KUMAR
发明人： JAIN RAJESH , TREHAN SANJAY , DAS JAGATTARAN , KANWAR SANDEEP , MAGADI SITARAM KUMAR
IPC分类号： C07F9/40
CPC分类号： C07F9/657154 , C07F9/650958 , C07F9/65583 , C07F9/65586 , C07F9/65846
摘要： The present invention relates to novel phenyl oxazolidinone compounds of Formula I, their pharmaceutically acceptable derivatives, tautomeric forms, stereoisomers including R and S isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to the processes for the synthesis of novel compounds of Formula I, their pharmaceutically acceptable derivatives, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The present invention also provides pharmaceutical compositions comprising novel compounds of Formula I and methods of treating or preventing conditions caused by microbial infections. The compounds of the present invention are effective against a number of aerobic and/or anaerobic Gram positive and/or Gram negative pathogens such as multi drug resistant Staphylococcus spp., Streptococcus spp., Enterococcus spp., Bacterioides spp., Clostridia spp., H. influenza, Moraxella Spp., as well as acid-fast organisms such as Mycobacterium tuberculosis and the like.
摘要翻译：本发明涉及式I的新的苯基恶唑烷酮化合物，其药学上可接受的衍生物，互变异构体，包括R和S异构体的立体异构体，多晶型物，前药，代谢物，盐或溶剂化物。本发明还涉及合成式I的新化合物，其药学上可接受的衍生物，互变异构形式，立体异构体，多晶型物，前药，代谢物，盐或溶剂合物的方法。本发明还提供包含式I的新化合物和治疗或预防由微生物感染引起的病症的方法的药物组合物。本发明的化合物对多种需氧和/或厌氧革兰氏阳性和/或革兰氏阴性病原体有效，例如耐多药耐药的葡萄球菌属，链球菌属，肠球菌属，细菌属（Clostridia spp。）， H.流感，Moraxella Spp。以及耐酸生物如结核分枝杆菌等。

3. 发明申请

WO2010058423A3 NOVEL ANTIMICROBIALS 审中-公开
标题翻译：新的抗生素
公开(公告)号：WO2010058423A3
公开(公告)日：2010-12-09
申请号：PCT/IN2009000658
申请日：2009-11-18
申请人： PANACEA BIOTEC LTD , JAIN RAJESH , TREHAN SANJAY , DAS JAGATTARAN , KANWAR SANDEEP , MAGADI SITARAM KUMAR , SHARMA SUDHIR KUMAR
发明人： JAIN RAJESH , TREHAN SANJAY , DAS JAGATTARAN , KANWAR SANDEEP , MAGADI SITARAM KUMAR , SHARMA SUDHIR KUMAR
IPC分类号： C07D413/10 , C07D413/14
CPC分类号： C07D487/04 , C07D263/20 , C07D413/12 , C07D413/14 , C07D417/12
摘要： The present invention relates to novel phenyl oxazolidinone compounds of formula I, their pharmaceutically acceptable analogs, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to the processes for the synthesis of novel compounds of formula I or their pharmaceutically acceptable analogs, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The present invention also provides pharmaceutical compositions comprising novel compounds of formula I and methods of using them. The compounds of the present invention are useful as antimicrobial agents, effective against a number of aerobic and/or anaerobic Gram positive and/or Gram negative pathogens such as multi drug resistant species of Staphylococcus, Streptococcus, Enterococcus, Bacterioides, Clostridia, H. influenza, Moraxella, acid-fast organisms such as Mycobacterium tuberculosis as well as Linezolid resistant species of Staphylococcus and Enterococcus.
摘要翻译：本发明涉及式I的新型苯基恶唑烷酮化合物，其药学上可接受的类似物，互变异构形式，立体异构体，多晶型物，前药，代谢物，盐或溶剂化物。本发明还涉及合成新型式I化合物或其药学上可接受的类似物，互变异构体形式，立体异构体，多晶型物，前药，代谢物，盐或溶剂合物的方法。本发明还提供了包含新颖的式I化合物和使用它们的方法的药物组合物。本发明的化合物可用作抗微生物剂，对许多需氧和/或厌氧革兰氏阳性和/或革兰氏阴性病原体有效，如葡萄球菌，链球菌，肠球菌，细菌，梭菌，流感嗜血杆菌，莫拉氏菌，耐酸菌，如结核分枝杆菌，以及耐盐霉菌属的霉菌和肠球菌。

4. 发明申请

WO2010150281A2 NOVEL AZABICYCLOHEXANES 审中-公开
标题翻译：新的雅各布
公开(公告)号：WO2010150281A2
公开(公告)日：2010-12-29
申请号：PCT/IN2010/000428
申请日：2010-06-22
申请人： PANACEA BIOTEC LTD. , JAIN, Rajesh , TREHAN, Sanjay , DAS, Jagattaran , KAUR, Gurmeet , KANWAR, Sandeep , SINGH, Nishan , NANDA, Gurmeet Kaur , MAGADI, Sitaram Kumar , SHARMA, Sudhir Kumar
发明人： JAIN, Rajesh , TREHAN, Sanjay , DAS, Jagattaran , KAUR, Gurmeet , KANWAR, Sandeep , SINGH, Nishan , NANDA, Gurmeet Kaur , MAGADI, Sitaram Kumar , SHARMA, Sudhir Kumar
IPC分类号： C07D221/22 , C07D401/10 , C07D413/10 , C07D413/14 , C07D417/10 , C07D471/04 , C07D491/08 , A61K31/46 , A61K31/496 , A61K31/498 , A61K31/5355 , A61K31/551 , C07D487/04 , A61P25/00 , A61P31/00
CPC分类号： C07D221/22 , C07D209/52 , C07D401/10 , C07D409/04 , C07D413/10 , C07D413/14 , C07D417/10 , C07D417/14 , C07D471/04 , C07D487/04 , C07D491/08
摘要： The present invention relates to novel compounds of Formula (I), their pharmaceutically acceptable derivatives, tautomeric forms, stereoisomers including R and S isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to processes for the synthesis of novel compounds of Formula I, their pharmaceutically acceptable derivatives, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof.
摘要翻译：本发明涉及式（I）的新化合物，其药学上可接受的衍生物，互变异构体，立体异构体，包括R和S异构体，多晶型物，前药，代谢物，盐或溶剂化物。本发明还涉及合成式I的新化合物，其药学上可接受的衍生物，互变异构体形式，立体异构体，多晶型物，前药，代谢物，盐或溶剂合物的方法。

5. 发明申请

WO2010150281A3 NOVEL AZABICYCLOHEXANES 审中-公开
标题翻译：新的雅各布
公开(公告)号：WO2010150281A3
公开(公告)日：2011-04-21
申请号：PCT/IN2010000428
申请日：2010-06-22
申请人： PANACEA BIOTEC LTD , JAIN RAJESH , TREHAN SANJAY , DAS JAGATTARAN , KAUR GURMEET , KANWAR SANDEEP , SINGH NISHAN , NANDA GURMEET KAUR , MAGADI SITARAM KUMAR , SHARMA SUDHIR KUMAR
发明人： JAIN RAJESH , TREHAN SANJAY , DAS JAGATTARAN , KAUR GURMEET , KANWAR SANDEEP , SINGH NISHAN , NANDA GURMEET KAUR , MAGADI SITARAM KUMAR , SHARMA SUDHIR KUMAR
IPC分类号： C07D221/22 , A61K31/46 , A61K31/496 , A61K31/498 , A61K31/5355 , A61K31/551 , A61P25/00 , A61P31/00 , C07D401/10 , C07D413/10 , C07D413/14 , C07D417/10 , C07D471/04 , C07D487/04 , C07D491/08
CPC分类号： C07D221/22 , C07D209/52 , C07D401/10 , C07D409/04 , C07D413/10 , C07D413/14 , C07D417/10 , C07D417/14 , C07D471/04 , C07D487/04 , C07D491/08
摘要： The present invention relates to novel compounds of Formula (I), their pharmaceutically acceptable derivatives, tautomeric forms, stereoisomers including R and S isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to processes for the synthesis of novel compounds of Formula I, their pharmaceutically acceptable derivatives, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof.
摘要翻译：本发明涉及式（I）的新化合物，其药学上可接受的衍生物，互变异构体，立体异构体，包括R和S异构体，多晶型物，前药，代谢物，盐或溶剂化物。本发明还涉及合成式I的新化合物，其药学上可接受的衍生物，互变异构体形式，立体异构体，多晶型物，前药，代谢物，盐或溶剂合物的方法。

6. 发明申请

WO2010058423A2 NOVEL ANTIMICROBIALS 审中-公开
标题翻译：新的抗微生物剂
公开(公告)号：WO2010058423A2
公开(公告)日：2010-05-27
申请号：PCT/IN2009000658
申请日：2009-11-18
申请人： PANACEA BIOTEC LTD , JAIN RAJESH , TREHAN SANJAY , DAS JAGATTARAN , KANWAR SANDEEP , MAGADI SITARAM KUMAR , SHARMA SUDHIR KUMAR
发明人： JAIN RAJESH , TREHAN SANJAY , DAS JAGATTARAN , KANWAR SANDEEP , MAGADI SITARAM KUMAR , SHARMA SUDHIR KUMAR
IPC分类号： C07D413/10 , C07D413/14
CPC分类号： C07D487/04 , C07D263/20 , C07D413/12 , C07D413/14 , C07D417/12
摘要： The present invention relates to novel phenyl oxazolidinone compounds of formula I, their pharmaceutically acceptable analogs, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to the processes for the synthesis of novel compounds of formula I or their pharmaceutically acceptable analogs, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The present invention also provides pharmaceutical compositions comprising novel compounds of formula I and methods of using them. The compounds of the present invention are useful as antimicrobial agents, effective against a number of aerobic and/or anaerobic Gram positive and/or Gram negative pathogens such as multi drug resistant species of Staphylococcus, Streptococcus, Enterococcus, Bacterioides, Clostridia, H. influenza, Moraxella, acid-fast organisms such as Mycobacterium tuberculosis as well as Linezolid resistant species of Staphylococcus and Enterococcus.
摘要翻译：本发明涉及式I的新型苯基恶唑烷酮化合物，其药学上可接受的类似物，互变异构形式，立体异构体，多晶型物，前药，代谢物，盐或溶剂化物。本发明还涉及合成式I的新化合物或其药学上可接受的类似物，互变异构形式，立体异构体，多晶型物，前药，代谢物，盐或溶剂合物的方法。本发明还提供了包含新型式I化合物和使用它们的方法的药物组合物。本发明化合物可用作抗微生物剂，有效对抗许多需氧和/或厌氧革兰氏阳性和/或革兰氏阴性病原体，例如葡萄球菌，链球菌，肠球菌，细菌，梭菌，流感嗜血菌，莫拉菌属（Moraxella），耐酸生物体如结核分枝杆菌（Mycobacterium tuberculosis）以及耐利奈唑胺菌（Staphylococcus and Enterococcus）。

7. 发明申请

WO2009116090A3 NOVEL ANTIMICROBIALS 审中-公开
公开(公告)号：WO2009116090A3
公开(公告)日：2009-09-24
申请号：PCT/IN2009/000184
申请日：2009-03-17
申请人： PANACEA BIOTEC LIMITED , JAIN, Rajesh , TREHAN, Sanjay , DAS, Jagattaran , KANWAR, Sandeep , MAGADI, Sitaram, Kumar
发明人： JAIN, Rajesh , TREHAN, Sanjay , DAS, Jagattaran , KANWAR, Sandeep , MAGADI, Sitaram, Kumar
IPC分类号： C07F9/6571 , C07F9/6509 , C07F9/6584 , C07F9/6558
摘要： The present invention relates to novel phenyl oxazolidinone compounds of Formula I, their pharmaceutically acceptable derivatives, tautomeric forms, stereoisomers including R and S isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to the processes for the synthesis of novel compounds of Formula I, their pharmaceutically acceptable derivatives, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The present invention also provides pharmaceutical compositions comprising novel compounds of Formula I and methods of treating or preventing conditions caused by microbial infections. The compounds of the present invention are effective against a number of aerobic and/or anaerobic Gram positive and/or Gram negative pathogens such as multi drug resistant Staphylococcus spp., Streptococcus spp., Enterococcus spp., Bacterioides spp., Clostridia spp., H. influenza , Moraxella Spp., as well as acid-fast organisms such as Mycobacterium tuberculosis and the like.

8. 发明申请

WO2008090570A1 NOVEL ANTIMICROBIALS 审中-公开
标题翻译：新的抗生素
公开(公告)号：WO2008090570A1
公开(公告)日：2008-07-31
申请号：PCT/IN2008/000047
申请日：2008-01-24
申请人： PANACEA BIOTEC LTD , JAIN, Rajesh , TREHAN, Sanjay , DAS, Jagattaran , KAUR, Gurmeet , KANWAR, Sandeep , MAGADI, Sitaram, Kumar
发明人： JAIN, Rajesh , TREHAN, Sanjay , DAS, Jagattaran , KAUR, Gurmeet , KANWAR, Sandeep , MAGADI, Sitaram, Kumar
IPC分类号： C07F9/6584 , C07D413/10 , A61K31/495
CPC分类号： C07F9/6584
摘要： The present invention relates to novel phenyl oxazolidinone compounds of formula (I) or their pharmaceutically acceptable analogs, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to the processes for the synthesis of novel compounds of formula (I) or their pharmaceutically acceptable analogs, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The present invention also provides pharmaceutical compositions comprising novel compounds of formula I and methods of using them. The compounds of the present invention are useful as antimicrobial agents, effective against a number of aerobic and/or anaerobic Gram positive and/or Gram negative pathogens such as multi drug resistant Staphylococcus spp., Streptococcus spp., Enterococcus spp., Bacterioides spp., Clostridia spp., H. influenza , Moraxella Spp., as well as acid-fast organisms such as Mycobacterium tuberculosis and the like.
摘要翻译：本发明涉及式（I）的新的苯基恶唑烷酮化合物或其药学上可接受的类似物，互变异构形式，立体异构体，多晶型物，前药，代谢物，盐或溶剂合物。本发明还涉及合成式（I）的新型化合物或其药学上可接受的类似物，互变异构形式，立体异构体，多晶型物，前药，代谢物，盐或溶剂合物的方法。本发明还提供了包含新颖的式I化合物和使用它们的方法的药物组合物。本发明的化合物可用作抗微生物剂，对多种需氧和/或厌氧革兰氏阳性和/或革兰氏阴性病原体有效，如多药耐药葡萄球菌，链球菌属，肠球菌属，细菌属，，梭菌属（Clostridia spp。），流感嗜血杆菌（H. influenza），莫拉氏菌（Moraxella Spp。）以及耐酸生物如结核分枝杆菌等。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式